Industry insiders invited to take Q3 BioPharma Sentiment Survey

Signal's Endpoints team is launching the third quarterly BioPharma Sentiment Index (BPSI) survey, a three minute questionnaire that captures industry views.

The survey asks participants to share perspectives on science, finance, hiring and regulation, and aims to provide a clear benchmark for the sector each quarter.

Approximately 1,000 industry insiders responded in the previous quarter, and the new round seeks similar participation to keep the benchmark representative and relevant.

Responses are anonymous and participants will receive a complimentary copy of the report once it is compiled.